Ototoxicity exemplified by aminoglycosides and cisplatin: is there a specific antidote
Dieler, R.; Shehata-Dieler, W.E.
Hno 42(9): 525-528
1994
ISSN/ISBN: 0017-6192 PMID: 7989223 Document Number: 436514
Document emailed within 1 workday
Related Documents
Peytral, C.; Henin, J.M.; Vacher, S.; Israel, V. 1981: Cisplatin ototoxicity Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 98(3): 85-88Qureshy, K.; Blakley, B.; Alsaleh, S.; Quddusi, T.; Berard, S. 2011: End points for cisplatin ototoxicity Journal of Otolaryngology - Head and Neck Surgery 40(Suppl 1): S45-S48
Rybak, L.P.; Husain, K.; Morris, C.; Whitworth, C.; Somani, S. 2000: Effect of protective agents against cisplatin ototoxicity American Journal of Otology 21(4): 513-520
Iraz, M.; Kalcioglu, M.Tayyar.; Kizilay, A.; Karatas, E. 2005: Aminoguanidine prevents ototoxicity induced by cisplatin in rats Annals of Clinical and Laboratory Science 35(3): 329-335
Helt-Cameron, J.; Allen, P.J. 2009: Cisplatin ototoxicity in children: implications for primary care providers Pediatric Nursing 35(2): 121-127
Tang, Y.; Wang, P.; Du, B.; Zhou, B.; Du, B.-d. 2008: Expressions of neurotrophin factor receptor in spiral ganglion cell of cisplatin-induced ototoxicity Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 43(12): 950-955
2015: Dabigatran specific antidote: new safety level in oral anticoagulation MMW Fortschritte der Medizin 157(19): 78-79
Kurlemann, G.; Jorch, G.; Lunkenheimer, A.; Hilgenberg, F. 1985: Treatment of digitalis poisoning with a specific digitalis antidote Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 133(7): 495-496
Stoschitzky, K.; Lindner, W. 1990: Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol Wiener Medizinische Wochenschrift 140(6-7): 156-162
Dorie, M.J.; Brown, J.M. 1993: Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin Cancer Research 53(19): 4633-4636
Takano, M.; Goto, T.; Hirata, J.; Furuya, K.; Horie, K.; Takahashi, M.; Yokota, H.; Kino, N.; Kudoh, K.; Kikuchi, Y. 2013: UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study European Journal of Gynaecological Oncology 34(2): 120-123
Kobayashi, H. 1985: Cisplatin and ovarian carcinoma--early detection of cisplatin-induced nephrotoxicity Nihon Sanka Fujinka Gakkai Zasshi 37(6): 888-896
Makhnova, E.V. 2003: Combination chemotherapy with Hemzar (gemcitabine) and cisplatin for relapsing and cisplatin-resistant ovarian cancer Voprosy Onkologii 49(1): 60-65
Zhao, J. 1985: Cisplatin or combined cisplatin and 60Co radiation in the treatment of advanced lung cancer--report of 145 cases Zhonghua Zhong Liu Za Zhi 7(4): 283-285
González-Larriba, J.L.; Garcia Carbonero, I.; Sastre Valera, J.; Perez Segura, P.; Diaz-Rubio, E. 1997: Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer Oncology 11(9 Suppl 10: 90-97
Kudoh, K.; Kita, T.; Hirata, J.; Ishii, K.; Hiramatsu, H.; Kikuchi, Y.; Nagata, I. 1994: Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine Nihon Sanka Fujinka Gakkai Zasshi 46(6): 525-532
Yu, Y.; Zhang, X.; Tian, H.; Zhang, Z.; Tian, Y. 2018: Knockdown of long non-coding RNA HOTAIR increases cisplatin sensitivity in ovarian cancer by inhibiting cisplatin-induced autophagy Journal of BUON: Official Journal of the Balkan Union of Oncology 23(5): 1396-1401
Johnson, S.W.; Swiggard, P.A.; Handel, L.M.; Brennan, J.M.; Godwin, A.K.; Ozols, R.F.; Hamilton, T.C. 1994: Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells Cancer Research 54(22): 5911-5916
Fichtinger-Schepman, A.M.; Vendrik, C.P.; van Dijk-Knijnenburg, W.C.; de Jong, W.H.; van der Minnen, A.C.; Claessen, A.M.; van der Velde-Visser, S.D.; de Groot, G.; Wubs, K.L.; Steerenberg, P.A. 1989: Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma Cancer Research 49(11): 2862-2867
Sukhaboon, J.; Porapakkhan, P.; Penpattanagul, S. 2009: Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study Journal of the Medical Association of Thailand 92(8): 1072-1076